In acute lymphoblastic leukaemia (ALL), phase I/II trials compare the administration of RBC-load L-asparaginase with natural L-asparaginase, which was aimed to investigate the relationship between RBC-load L-asparaginase and duration of asparagine depletion (NCT00723346). The gene discussed is ASPG; the disease is acute lymphoblastic leukemia.